Evaluation of Human Brain Tumor Therapy Response by Magnetic Resonance (MR)
The purpose of this study is to determine if new MRI methods that measure various information and chemical makeup in the brain, will give early information regarding response to treatment in patients with brain tumors.
|Study Design:||Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
|Official Title:||Quantitation of Human Brain Tumor Therapy Response by MR|
- To determine if new MRI methods that measure information related to the brain will give an earlier determination as to how well patients with brain tumors are responding to treatment. [ Time Frame: approximately 1 year ] [ Designated as safety issue: No ]
|Study Start Date:||September 1999|
|Estimated Study Completion Date:||September 2015|
|Estimated Primary Completion Date:||December 2014 (Final data collection date for primary outcome measure)|
Evaluation of new MRI methods that measure information related to the chemical makeup of the brain in patients undergoing therapy for brain tumors.
New MRI methods which measure information related to water, blood, and chemical makeup in the brain.
The purpose of this study is to see if new MRI methods which measure information related to water, blood flow, and chemical makeup in the brain, can give early information of how well treatment is working in patients with brain tumors.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00724191
|United States, Michigan|
|Univeristy of Michigan Health System|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||Thomas L. Chenevert, Ph.D||University of Michigan|